Dr. Lal Pathlabs Ltd

NSE: LALPATHLAB · BSE: 539524 · Healthcare · 56 announcements

Share price: ₹1,945.10
Market cap: ₹32,648 Cr
Revenue (annual): ₹2,763 Cr
Net profit (annual): ₹504.8 Cr
P/E (TTM): 60.2×Sector 53.1×
Promoter holding: 53.19%-0.02% QoQ
FII holding: 17.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Acquisition 7 Other Announcement 5 Employee Stock Options 4 Merger & Restructuring 3 Legal & Regulatory 2 Financial Results 2 Board Meeting Date 2 Results Update 1 Management Change 1 Earnings Call 1 Dividend 1 Capital Structure Change 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

19 Aug 2026 18:24 IST BSE

Merger & Restructuring

Dr. Lal Pathlabs Merger & Restructuring

Dr. Lal PathLabs' subsidiary, Dr Lal PathLabs FZCO, has incorporated a new step-down subsidiary, Dr Lal PathLabs Indomed LLC, in Tashkent, Uzbekistan, acquiring a 70% stake.

Read the filing ↗

24 Jul 2026 15:20 IST NSE

Merger & Restructuring

Dr. Lal Pathlabs Merger & Restructuring Worth ₹38 Cr

Dr. Lal Path Labs' subsidiary will acquire an 80% stake in Sunshine Healthcare Limited, Ghana. The transaction is valued at ₹38.0 Crore.

Value: ₹38.00 Cr
Execution: By August 31, 2026

Read the filing ↗

24 Jul 2026 15:19 IST NSE

Merger & Restructuring

Dr. Lal Pathlabs Merger & Restructuring Worth ₹3.5 Cr

Dr. Lal Path Labs' subsidiary, Dr. Lal Ventures, is acquiring a 30% stake in Neuome Technologies for ₹3.5 Crore. This provides access to innovative bio-banking solutions.

Value: ₹3.50 Cr
Execution: by 31-08-2026

Read the filing ↗